2023 Program Agenda

ABOUT THE BIOTECH CEO SUMMITS – UNLIKE ANY OTHER CONFERENCE

The Biotech CEO Summits are unlike most other meetings CEOs attend. The Summits focus on the participating CEOs discussing issues of importance to them as leaders of companies they want to position for growth and success. The Summits are discussion based meetings led by subject matter experts. All participants are invited to, and indeed encouraged to join the discussions by asking questions and sharing their personal insights. The Summits are run under Chatham House Rules to encourage open and frank conversation. The media are not invited, and the sessions are not recorded, to provide an extra layer of privacy.

Monday, July 17

2:00 pm

Registration Opens: Maurice Braun Foyer – via Lobby

3:00 pm

Pre-Event: Gathering for Female Biotech CEOs: Charles Fries Room
  • Ciara Kennedy, CEO, Sorriso Pharmaceuticals

5:00 pm

Welcome Networking Event: Arroyo Terrace
Drinks and Falconry Demonstration

6:30 pm

Opening Program: Everett Jackson Room
Welcome Remarks
  • Sara Jane Demy, Founder & CEO, Demy-Colton

6:45 pm

CEO Summit Participant Introductions
Self–Introductions by all participants

7:30 pm

Fireside Chat Series: The Purposeful CEO – Fulfilling the Promise
Leading a team through change, innovation, and the challenges of bringing therapeutics to patients while the rules are still being written
Moderator:
  • Seema Kumar, CEO, Cure
Fireside Chat CEO:
  • Eric Dube, CEO, Travere Therapeutics

8:15 pm

Networking Reception & Dinner: Alfred Mitchell Room

Tuesday, July 18

7:00 am

Private Networking Breakfast: Charles Reiffel Room

8:20 am

Summit Overview & Rules of Engagement: Maurice Braun Room
  • Sara Jane Demy, Founder & CEO, Demy-Colton

8:30 am

Opening Discussion: Looking at The Crystal Ball
Discussion Leader:
  • Tim Opler, Managing Director, Emerald BioVentures
Discussants:
  • Rachelle Jacques, CEO, Akari Therapeutics
  • Gabriel Cavazos, Senior Managing Director, SVB Securities

9:15 am

Managing What You Have: Taking Your Foot Off the Accelerator Now While Preparing To Go Full Throttle Later
Discussion Leader:
  • Kale Frank, Managing Director, Life Science and Healthcare, SVB
Discussants:
  • Sandra Dunn, CEO, Phoenix Molecular Designs
  • Thijs Spoor, CEO, Perspective Therapeutics
  • Nancy Stagliano, CEO, Neuron23

10:00 am

Networking Break: Maurice Braun Patio

10:15 am

Creative Financing in Challenging Times: The Tools, Options, and Novel Approaches
Discussion Leader:
  • Carlos Ramirez, Partner, Cooley
Discussants:
  • Gabriel Cavazos, Senior Managing Director, SVB Securities
  • Rachelle Jacques, CEO, Akari Therapeutics
  • Michael Tilghman, Director, SVB

11:00 am

Asset Value Versus Enterprise Value: It’s Not What You Think
Discussion Leader:
  • Ted Haack, Vice President, LatticePoint
Discussants:
  • Sandra Dunn, CEO, Phoenix Molecular Designs
  • Ciara Kennedy, CEO, Sorriso Pharmaceuticals
  • Tim Opler, Partner, Emerald BioVentures

11:45 am

Building Value Through the Company Lifecycle: The Key to Successful BD & Fundraising
Discussion Leader:
  • Lila Hope, Partner, Cooley
Discussants:
  • Kerrie Brady, CEO, OcuTerra Therapeutics
  • Michael McCully, CEO, Gate Neurosciences Inc.
  • Thomas Tóth von Kiskér, CEO, Tillotts Pharma

12:30 pm

Networking Lunch: Arroyo Terrace

1:45 pm

A Case Study: The Finishing Touch: Maurice Braun Room
Discussion Leaders:
  • Ted Haack, Vice President, LatticePoint
  • Brandi Simpson, Vice President, BD, Voyager
  • Robin Toft, Global Life Sciences & Boardroom Diversity Advisor, ZRG Partners

2:00 pm

Breakout Groups Report Out: Charles Fries Room & Charles Reiffel Room

2:30 pm

Breakouts Report Back: Maurice Braun Room
Teams Reconvene: Each team will present the specific challenges the CEO of their company faced and their recommendations for handling the situation.
Discussion Leaders:
  • Ted Haack, Vice President, LatticePoint
  • Brandi Simpson, Vice President, BD, Voyager
  • Robin Toft, Global Life Sciences & Boardroom Diversity Advisor, ZRG Partners

3:15 pm

AI in Biotech: Why We Should Care
Discussion Leader:
  • Bassil Dahiyat, CEO, Xencor, Inc.
Discussants:
  • Jacob Berlin, CEO, Terray Therapeutics
  • Benjamin Pensak, Partner, Morgan Lewis
  • Julie Visser, Managing Director, Executive Search, Human Capital Advisory Team, ZRG Partners, LLC

4:00 pm

The IRA: How Will the Rules Affect Innovation and Your Business
Discussion Leader:
  • Seema Kumar, CEO, Cure
Discussants:
  • Paul Hastings, CEO, Nkarta Therapeutics
  • Joseph Panetta, President & CEO, Biocom California

5:00 pm

Day 1 Wrap-Up & Instructions for CEO Summit Games
  • Sara Jane Demy, Founder & CEO, Demy-Colton
  • Kari Bennett, Senior Marketing Advisor, Demy-Colton

5:15 pm

Biotech CEO Summit Games: Arroyo Terrace

7:15 pm

Break

7:45 pm

Networking Reception: Charles Fries Patio</strong

8:30 pm

Biotech CEO Summit Gala Awards & Dinner: Charles Reiffel Room

Wednesday, July 19

7:00 am

Private Networking Breakfast: Charles Reiffel Room

8:25 am

Welcome Back & Day 2 Commences: Maurice Braun Room
  • Sara Jane Demy, Founder & CEO, Demy-Colton

8:30 am

Communications: The Building Blocks for Successful Fundraising, Deal Making & Team Building – Especially in Challenging Times

Discussion Leader:

  • Erik Clausen, Managing Partner, CG Life

Discussants:

  • Virginia Amann, CEO, Founder & Shareholder, ENTENTE Network
  • Dee Datta, CEO, Switch Therapeutics

9:30 am

Your Board: Building the Trust and Engagement to Support Success

Discussion Leader:

  • Julie Visser, Managing Director, Executive Search, Human Capital Advisory Team, ZRG Partners, LLC

Discussants:

  • Paul Hastings, CEO, Nkarta & Former Chair, BIO
  • Joseph Payne, CEO, Arcturus Therapeutics
  • Leslie Williams, CEO, hC Bioscience

10:30 am

Networking Break: Maurice Braun Patio

10:45 am

“Fit-for-Purpose”: Building, Scaling, and Evolving a Successful Biotech Company
Discussion Leader:
  • David Fortier, Managing Partner, Global Life Sciences Practice Leader, ZRG Partners
Discussants:
  • Michael Bailey, CEO, AVEO Oncology
  • Bassil Dahiyat, CEO, Xencor, Inc.
  • Nancy Stagliano, CEO, Neuron23

11:45 am

Big, Bold Ideas: Building a Better, More Sustainable Biotech Community
Discussion Leader:
  • Jeffrey Cleland, Chairman, CEO & President, Ashvattha Therapeutics
Discussants:
  • Eric Dube, President & CEO, Travere Therapeutics, Inc.
  • Sofie Qiao, CEO, Vivace Therapeutics, Inc.

12:30 pm

Networking Lunch: Arroyo Terrace

1:45 pm

Fireside Chat Series: The Purposeful CEO – Fulfilling the Promise: Maurice Braun Room
Building a company to address an unmet need.
Moderator:
  • Lila Hope, Partner, Cooley
Fireside Chat CEO:
  • Ted Love, Chairman, Biotechnology Industry Organization (BIO)

2:30 pm

An Unguarded Conversation Among Friends

  • Sara Jane Demy, Founder & CEO, Demy-Colton

3:00 pm

Wrap-Up Biotech CEO Summit
  • Sara Jane Demy, Founder & CEO, Demy-Colton

3:15 pm

Closing Reception: Charles Fries Patio